A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

NCT00236587 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: risperidone

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.